Laser-assisted low-dose retinoic acid in oral cancer chemoprevention

Laryngoscope

Volumn 115, Issue 2, 2005, Pages 283-286

  Driver, Mark ^a   Upadhyay, Urmen D ^b   Shapshay, Stanley M ^a   Wang, Zhi ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Chemoprevention; Laser; Retinoic acid

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY BURDEN; CHEEK POUCH; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DYSPLASIA; HAMSTER; HYPOTHESIS; INFLAMMATION; IRRADIATION; LASER; LOW DRUG DOSE; MALE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEEK; CRICETINAE; DISEASE MODELS, ANIMAL; LASER SURGERY; MALE; MESOCRICETUS; MOUTH MUCOSA; MOUTH NEOPLASMS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; TRETINOIN;

EID: 13444262296     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000154734.54152.9a     Document Type: Article

References (14)

1. Thawley SE, Batsakis JG, Lindberg RD. Comprehensive Management of Head and Neck Tumors. Philadelphia: W.B. Saunders Company, 1999.
2. Ha P, Caligano J. The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 2002;35:993-1012.
3. Lingen MW, Chang KW, McMurray SJ, et al. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck 2000;22:328-335.
4. Strong S, Incze J, Vaughan C. Field Cancerization in the aerodigestive tract: its etiology, manifestation, and significance. J Otolaryngol 1984;13:1-5.
5. Lippman SM, Heyman RA, Kurie JM, et al. Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem Suppl 1995;22:1-10.
6. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley PM, eds. The molecular basis of cancer. Philadelphia, PA: WB Saunders, 1995:206-232.
7. Polavaram R, Fuentes CF, Shapshay SM, Wang Z. The role of laser vascular targeting and retinoic acid in oral cancer inhibition. Laryngoscope 2003;113:715-719.
8. Shah RK, Valdez TA, Wang Z, Shapshay SM. Pulsed-dye laser and retinoic acid delay progression of oral squamous cell carcinoma: a murine model. Laryngoscope 2001;111:1203-1208.
9. Loo WJ, Lanigan SW. Recent advances in laser therapy for the treatment of cutaneous vascular disorders. Lasers Med Sci 2002;17:9-12.
10. McMillan K, Shapshay SM, McGilligan JA, et al. A 585 nanometer pulsed-dye laser treatment of laryngeal papillomas, preliminary report. Laryngoscope 1998;108:968-972.
11. Miller WH. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998;83:1471-82.
12. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003;22:7305-7315.
13. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New Engl J Med 1990;323:795-801.
14. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-968.